Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Vertex Stock Up 40 Percent After Cystic Fibrosis Trial Results 06/24/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop 10/29/13 Boston
New Data Could Open Vertex’s CF Drug to 400 More Patients 07/29/13 Boston
Supply Chains Are Orderly. Biotech Innovation Is Messy 04/30/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Got Cancer? Sorry, There’s No App for That 01/10/13 Seattle
Build It In The Back Yard: Why We Need American Manufacturing 12/14/12 Boston
Three Big Themes from the Personalized Medicine Conference 12/05/12 Boston
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
The New Power Players in Drug R&D Are Wearing Bright T-Shirts 10/29/12 National
Third Rock’s MyoKardia Gets $38M for Genetic Forms of Heart Disease 09/20/12 San Francisco
Vertex Wins EU Approval for Cystic Fibrosis Drug 07/27/12 Boston
Tesaro, Vertex, Infraredx, & More Boston Life Sciences Headlines 06/29/12 Boston
After Big Oops, Vertex Plows Ahead With Cystic Fibrosis Drug Combo 06/28/12 Boston
Vertex Shares Drop on Mistake in Cystic Fibrosis Drug Data 05/29/12 Boston
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More 05/10/12 San Diego
Vertex Shares Boom on Cystic Fibrosis Results 05/07/12 Boston
Investing in Biotech Isn’t Just for Investors Anymore 04/09/12 National
Late Add: John Mendlein Joins “Reinventing Biotech” Lineup April 3 03/29/12 Seattle
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks 03/26/12 National
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says 02/01/12 Boston
Page 1 of 2 next page »